Physician profile
May Nour
NPI 1366679508
$32,080.65
in general payments reported to CMS, 2019-2025
14 companies · $8,909 in 2025
The $8,909 reported for 2025 was more than what 91% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,132 · 2020: $3,456 · 2021: $2,007 · 2022: $463 · 2023: $7,026 · 2024: $1,087 · 2025: $8,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Consulting Fee: $4,454 · Food and Beverage: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,144.67 |
| Consulting Fee | $4,453.50 |
| Food and Beverage | $1,424.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $16,789.67 | 2019-2025 | Somatom On.Site, Somatom Pro.Pulse |
| Samsung Hme America, INC. | $6,473.70 | 2020-2023 | |
| Astrazeneca Ab | $2,953.50 | 2023-2025 | Andexxa |
| Medtronic USA, INC. | $2,157.07 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,309.00 | 2021 | |
| Balt USA, LLC | $556.66 | 2020-2024 | Optima Coil System |
| Stryker Corporation | $453.09 | 2023-2025 | Surpass Evolve, Target, Universal Neuro 3 |
| Depuy Synthes Sales INC. | $383.86 | 2021-2025 | Embotrap |
| Medtronic, INC. | $341.15 | 2021-2025 | Solitaire X |
| Phenox INC. | $231.45 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $197.33 | 2021-2022 | |
| Microvention, INC. | $193.28 | 2021-2022 | |
| Penumbra, INC. | $40.89 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May Nour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.